Medicaid enrollment in Missouri begins; applications appear vigorous

Written by Timothy McBride, co-director, Center for Health Economics and Policy The expansion of Medicaid in Missouri began in 2021, and after resolution of a lawsuit at the Missouri Supreme Court in July, enrollment applications were accepted starting on October 2021. As of January 21, 2022, enrollment in the adult expansion group (AEG) had reached […]

Michael S. Kinch, PhD

Dr. Kinch examines the practices and organizations involved in research and development of new therapeutic agents and devices. Specifically, he has evaluated people and organizations involved in the preclinical and clinical activities necessary for the approval of an FDA-approved drugs or devices. His work has further evaluated how these activities have changed over time, as […]

2020 in review: Center for Dissemination & Implementation works with state to inform COVID-19 response

Since March 2020, the Center for Dissemination and Implementation at the Institute for Public Health has partnered with both the St. Louis region and the state of Missouri to provide data analysis and modeling related to COVID-19. These partnerships influenced the region to issue shelter-in-place orders sooner than they might have, allowed state officials to […]

Targeting RANK pathway in mammographic density and breast cancer prevention

Written by Chee Teik Lee, medical student at University College Dublin and participant in the 2019 Institute for Public Health Summer Research Program – Public & Global Health Track Breast cancer is the most common invasive cancer in women. Age, obesity, and mammographic density are strong risk factors for breast cancer. Modifiable lifestyle factors such […]

Medicaid Work Requirements: What Would the Impact be in Missouri on Enrollment, Costs and Health?

Written by Linda Li, MPH, Abigail Barker, PhD, Leah Kemper, MPH, Timothy McBride, PhD | February 2019 In 2018, the Centers for Medicare and Medicaid Services (CMS) announced support for state efforts to condition Medicaid coverage on fulfilling a work requirement. For the first time in the program’s history, certain beneficiaries can be required to […]

Precision medicine research in diverse populations

Written by Erin Linnenbringer, PhD, MS, assistant professor in the Department of Surgery, School of Medicine At the time of publishing, professor Linnenbringer was an instructor in the Department of Surgery Essential to Meeting the Goal of Reaching the Right Patient With the Right Treatment at the Right Time Many Americans have probably heard the […]

Participating in a clinical trial

Written by Shea Roesel, clinical research coordinator I at Volunteer for Health at the School of Medicine As a clinical research coordinator with the Volunteer for Health (VFH) office at Washington University School of Medicine over the past 15 years, I have noticed that each participant’s situation is distinctive and the motivation to participate in […]

Healthspan is more important than lifespan, so why don’t more people know about it?

Written by Tim Peterson, assistant professor in the Department of Medicine at Washington University in St. Louis  While more and more people are taking an interest in aging and lifespan, awareness on healthspan lags (Figure 2). If you don’t know what healthspan means you aren’t alone. What is healthspan? Many might agree that “healthspan” can […]

Community Advisory Board

The Community Advisory Board (CAB) was established to help bridge the gap between university researchers and local communities. The CAB is comprised of a diverse group of individuals with strong ties to local communities within St. Louis and its surrounding counties. The CAB serves community-academic partnerships in several ways, including advising community-engaged research and activities. […]

Drug pricing: Where do we go after the election?

Martin Shkreli. Valeant Pharmaceuticals. Mylan. Just a year ago, most Americans devoted little time and attention to the question of pharmaceutical pricing. Now, after a series of highly publicized scandals involving individuals and companies who hike the prices of products like the EpiPen or Daraprim with impunity, public awareness of these issues has dramatically increased […]

Center for Health Economics & Policy funds two pilot projects

The Center for Health Economics and Policy (CHEP) pilot program announces funding for two projects in the inaugural round of funding from CHEP. The funding for these year-long projects begins on September 1, 2016. Correlates of Enactment of State Legislation Related to HPV Vaccines PI: Amy Eyler Human Papillomavirus (HPV) is the most common sexually transmitted […]

Access to PrEP: A “game changer” for HIV

The number of new HIV infections per year in St. Louis and nationally have not declined over the past 10 years despite the enormous amounts of money and energy spent on this issue. The medication used for PrEP, Truvada, is more than 90% effective when taken as one pill once a day. While PrEP is […]

Bringing a superfood down to earth

Genetically modified (GM) crops are mostly planted on large industrialized farms (mainly in the US, Brazil, and Argentina), but there continues to be keen interest in—and debate on—their utility for small farmers and poor consumers in the Global South. In this regard, “Golden Rice” has received the most attention. Golden Rice is a medical food, engineered […]

Bench to implementation in the real world

Our Global Health Center contacted speakers from it’s 2015 Global Health and Infectious Disease Conference to gain their perspectives on the event’s theme of taking research from bench to implementation. We spoke with: Daniel Colley, PhD, Professor, University of Georgia and Director, Center for Tropical and Emerging Infectious Diseases Helen Fletcher, PhD, Senior Lecturer at […]